Quick Answer
Bluejay Diagnostics, Inc. reported Total Assets of $7.12 million for fiscal year 2025.
Bluejay Diagnostics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.12M | +6.9% |
| 2024 | $6.66M | +36.7% |
| 2023 | $4.87M | -64.0% |
| 2022 | $13.52M | -35.7% |
| 2021 | $21.02M | +1285.3% |
| 2020 | $1.52M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.89M | -41.5% | -23.6% |
| June 30, 2025 | $6.40M | -41.0% | +21.3% |
| March 31, 2025 | $5.28M | +4.0% | -20.7% |
| December 31, 2024 | $6.66M | +36.7% | -20.3% |
| September 30, 2024 | $8.35M | +1.3% | -23.1% |
| June 30, 2024 | $10.86M | +28.1% | +114.0% |
| March 31, 2024 | $5.08M | -53.4% | +4.2% |
| December 31, 2023 | $4.87M | -64.0% | -41.0% |
- Bluejay Diagnostics, Inc. showed an increase of +6.9% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Bluejay Diagnostics, Inc.’s total assets has grown by 369.2% (from $1.52 million to $7.12 million).
- The most recent figure is from Bluejay Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: